Webinar: Diabetic PN with Rodica Pop Busui, MD, PhD
Demystifying Diabetic Peripheral Neuropathy with Rodica Pop Busui, MD, PhD
Nerve damage caused by diabetes, a condition called diabetic peripheral neuropathy (DPN), is a common and debilitating complication that most often affects the extremities. Patients with diabetic peripheral neuropathy often develop painful symptoms which is known as painful diabetic peripheral neuropathy or diabetic nerve pain.
Diabetic nerve pain can be an extremely challenging condition to diagnose, treat and manage effectively, and the excruciating pain patients may experience has a significant impact on their quality of life.
This webinar is designed to help patients recognize key symptoms associated with diabetic nerve pain of the feet (achiness, throbbing, burning sensations, etc.) and serve as a foundation to help empower patients to speak with their healthcare providers – fostering more productive conversations around diagnosis, disease management and potential solutions for painful diabetic neuropathy.
The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome Rodica Pop-Busui, MD, PhD, a prominent diabetologist at Michigan Medicine and a recognized leader in the field of diabetes and diabetes complications. Her research interests involve chronic complications of diabetes, particularly diabetic peripheral and cardiovascular autonomic neuropathy, as well as diabetic foot complications, diabetic kidney disease and cardiovascular disease, and the design and conduct of traditional and pragmatic clinical trials for patients with diabetes.
Webinar generously sponsored by Averitas Pharma and held live on Wednesday, September 7, 2022.
From Our Blog...
Ask the Expert: Popular Questions from PN Patients
Following the Foundation for Peripheral Neuropathy‘s (FPN) recent webinar on current research trends, Lindsay Colbert, FPN’s Executive Director, caught up with the program’s panelists, Dr.
Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain
Erchonia Corporation is currently recruiting for a study on the effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy pain. This study can be
Key Data from FPN Patient Registry Highlighted in Top Medical Journal
In January 2019, a study was published by the Journal of the Peripheral Nervous System on the design and characteristics of patient data collected from
Research Study for Painful Diabetic Peripheral Neuropathy
Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy.
Clinical Trial for Diabetic Peripheral Neuropathy
Northwestern University is conducting a Phase III clinical trial with Viromed Pharmaceuticals for an investigational drug (VM202) on painful, diabetic peripheral neuropathy in the legs
Treating Painful Diabetic Peripheral Neuropathy: An Update
Summary of journal article reviewing the current state of diabetic peripheral neuropathy treatment: Painful diabetic peripheral neuropathy occurs in approximately 25% of patients with diabetes